€561,909
▼ Sales (10 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by MALCOLM JAN. Director active across 1 company, notably UNITED THERAPEUTICS Corp. In total, 12 reports have been published. Split: 0 buy · 10 sells. Total volume traded: €562k. History available since 26 June 2025. The latest transaction was disclosed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations12 total
650 shares0Common StockSEC:0002028640-26-000007:0
325 shares@ US$550.59Common StockSEC:0002028640-26-000007:1
45 shares@ US$533.51100.0% of flowCommon StockSEC:0002028640-26-000006:0
50 shares@ US$509.205.4% of flowCommon StockSEC:0002028640-26-000005:0
50 shares@ US$474.68Common StockSEC:0002028640-26-000004:0
50 shares@ US$474.23Common StockSEC:0002028640-26-000003:0
50 shares@ US$460.98Common StockSEC:0002028640-26-000002:0
50 shares@ US$495.01Common StockSEC:0002028640-26-000001:0
50 shares@ US$512.127.2% of flowCommon StockSEC:0002028640-25-000006:0
50 shares@ US$482.987.3% of flowCommon StockSEC:0002028640-25-000005:0
700 shares@ US$400.2992.0% of flowCommon StockSEC:0002028640-25-000004:0
630 shares0Common StockSEC:0001562180-25-005511:0